Skip to contentP
Prestige Consumer Healthcare Inc.
P
PBHPrestige Consumer Healthcare Inc. Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$296.52M$296.52Mderived+7.0% vs Q4 2024 Net Income$50.13M$50.13Mderived+1.4% vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Prestige Consumer Healthcare Inc. · CIK 1295947 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$170,010,000+12.0% Operating Incomederived$88,428,000+7.6% Operating Cash Flowderived$61,848,000−7.6% Free Cash Flowderived$58,369,000−8.5% Margins · derivedGross margin57.3%+2.5 pt vs Q4 2024
Operating margin29.8%+0.2 pt vs Q4 2024
Net margin16.9%−0.9 pt vs Q4 2024
ended Mar 31, 2025 · filed May 9, 2025 · 39 d after period end